ABBVIE, INC. for ABBVIE INC.
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
H.R. 2673, American Innovation and R&D Competitiveness Act of 2023 S. 866, American Innovation and Jobs Act Public Law 115-97 (formerly known as H.R. 1, Tax Cuts and Jobs Act) Implementation Policy proposals relating to economic activity in Puerto Rico International tax issues, including OECD digital taxation work program
| Lobbyist | Covered position, as disclosed |
|---|---|
| DORCAS ADEKUNLE | — |
| DANIEL BACHNER | — |
| RACHEL DERBY | — |
| CRYSTAL RILEY | — |
| STEPHEN SCANGO | — |
Labor Issues/Antitrust/Workplace LBR
Issues related to antitrust and competition policy
| Lobbyist | Covered position, as disclosed |
|---|---|
| DORCAS ADEKUNLE | — |
| DANIEL BACHNER | — |
| RACHEL DERBY | — |
| CRYSTAL RILEY | — |
| STEPHEN SCANGO | — |
Copyright/Patent/Trademark CPT
S.142, Preserve Access to Affordable Generics and Biosimilars Act S. 2780, Medication Affordability and Patent Integrity Act Patent litigation reform issues and issues related to post-grant proceedings at the USPTO Value of intellectual property
| Lobbyist | Covered position, as disclosed |
|---|---|
| DORCAS ADEKUNLE | — |
| DANIEL BACHNER | — |
| RACHEL DERBY | — |
| CRYSTAL RILEY | — |
| STEPHEN SCANGO | — |
Health Issues HCR
H.R. 830, HELP Copays Act S.1375, HELP Copays Act H.R. 5378, Lower Costs, More Transparency Act S. 1339, Pharmacy Benefit Manager Reform Act Drug cost and pricing policy issues Patient affordability issues Policy proposals relating to clinical trial diversity Issues related to the 340B program
| Lobbyist | Covered position, as disclosed |
|---|---|
| DORCAS ADEKUNLE | — |
| DANIEL BACHNER | — |
| RACHEL DERBY | — |
| CRYSTAL RILEY | — |
| STEPHEN SCANGO | — |
Medicare/Medicaid MMM
Public Law 117-169 (formerly known as H.R. 5376, Inflation Reduction Act) Implementation regarding Medicare Part D drug negotiation program and smoothing out-of-pocket costs for patients Policy Proposals related to Medicare Part D and patient cost-sharing Department of Health and Human Services (HHS) drug policy issues and regulatory policy issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| DORCAS ADEKUNLE | — |
| DANIEL BACHNER | — |
| RACHEL DERBY | — |
| CRYSTAL RILEY | — |
| STEPHEN SCANGO | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.